Cullinan: Trading Way Below Cash
Seeking Alpha,
Summary Cullinan has one partnered lead asset and other early stage programs. The company is trading way below cash, which…
Summary Cullinan has one partnered lead asset and other early stage programs. The company is trading way below cash, which…
Cullinan Oncology’s Phase IIb study investigating CLN-081 in non-small cell lung cancer (NSCLC) patients with epidermal growth…